Question explored with the scientific record
How long can you feel under the weather from having Covid and flu jabs
The short version: most people feel rough for a day or two, but the studies here don't give you a clean single number, and the "under the weather" feeling can last longer for some.
The clearest data comes from a 2022 study of children with juvenile arthritis: after their mRNA shots, tiredness, muscle aches, headache, and fever were common, but all resolved within 1–2 days [3]. That matches the typical picture. A 2025 Sri Lankan study of working-age adults found symptoms were most common after the third dose, with about 6 in 10 people reporting something, but it doesn't state how long symptoms lasted [2]. A 2021 survey across three vaccines (Pfizer, AstraZeneca, Sinopharm) found mostly mild-to-moderate reactions, with a few unusual events lasting up to 13 days, like hand weakness or chest pain [1]. So the usual answer is 1–3 days, but outliers exist.
For flu shots, the only relevant study here is from 1983, testing an older subunit flu B vaccine. It found only mild local reactions and no systemic symptoms at all [4]. That's dated and doesn't reflect current flu vaccines, so treat it as weak evidence.
What's missing: no study here directly compares COVID and flu shots given together, and none tracks how long "under the weather" lasts in a general population with modern vaccines. The evidence is mostly short-term surveys, not rigorous trials with hard endpoints. The 2025 review linking spike protein persistence to long-term symptoms is speculative, not proof of duration [5].
My call: expect 1–3 days of feeling off after either shot, possibly longer after a booster, but the evidence for anything beyond that is thin. Confidence: moderate.
Sources used 5
-
Safety of COVID‐19 vaccines
A cross-sectional survey of 1,736 adults in Iraq and Jordan assessed post-vaccination adverse effects after Pfizer-BioNTech, AstraZeneca, and Sinopharm vaccines, finding generally mild to moderate reactogenicity with Sinopharm showing comparatively fewer adverse effects and seve…
DOI: 10.1002/jmv.27214 -
Prevalence, severity and duration of post-vaccination symptoms following COVID-19 vaccination in a working-aged population in Galle district, Sri Lanka
Post-vaccination symptoms are common among working-age adults in Galle District, Sri Lanka, peaking after the third COVID-19 vaccine dose and showing vaccine- and demographic-specific patterns.
DOI: 10.4038/cjs.v54i1.8343 -
Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience
A prospective cohort study of 36 children and adolescents with juvenile idiopathic arthritis found that the BNT162b2 mRNA COVID-19 vaccine was safe, producing mostly mild and transient local and systemic adverse events with no serious events and no disease flares.
DOI: 10.1186/s43166-022-00143-z -
A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection
In a randomized, blinded graded-dose trial, inactivated subunit influenza B vaccine was well tolerated and induced dose-dependent serum HI antibody; 20 or 40 microgram HA doses protected most volunteers against live attenuated RB77 challenge, with 50% protection at an HI titre o…
DOI: 10.1017/s0022172400063907 -
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?
This review posits that long COVID and post-COVID vaccine–related symptoms may be driven by spike protein–mediated activation of three interlinked immuno-inflammatory pathways—renin-angiotensin-aldosterone system (RAAS), kallikrein-kinin system (KKS), and the lectin complement p…
DOI: 10.3390/ijms26167879